close

LATEST POSTS from Anne-Lise Berthier

Pierre Fabre to commercialize and distribute the first approved allogeneic T-cell immunotherapy in Europe

Pierre Fabre to commercialize and distribute the first approved allogeneic T-cell immunotherapy in Europe Following transfer of the European Commission marketing authorization from Atara Biotherapeutics, Pierre Fabre is to lead launch and commercialization activities for  Ebvallo® (tabelecleucel) in Europe The french group Pierre Fabre and Atara Biotherapeutics, a californian biotech…..

Good news for quality control of mRNA medications

Good news for quality control of mRNA medications A mRNA molecule (p-RNA) is mixed with a standard (s-RNA) labelled with stable isotopes (SI) before being digested then characterized using a combination of liquid chromatography and mass spectrometry (LC-MS). The output is analyzed using Ariadne software to yield information on the…..

Creation of the Institut Pasteur-UCSF QBI Center of Excellence in Emerging Infectious Diseases

Creation of the Institut Pasteur-UCSF QBI Center of Excellence in Emerging Infectious Diseases Two academic and scientific heavyweights, the Institut Pasteur and UC San Francisco Quantitative Biosciences Institute (UCSF QBI), agree to implement joint actions towards the creation of a center of excellence in emerging infectious diseases with planned operations/locations…..

Longer life due to faulty RNA processing

Longer life due to faulty RNA processing [caption id="" align="aligncenter" width="700"] The roundworm Caenorhabditis elegans is an important model organism in ageing research. The worm in the image is labelled with GFP::RNP-6. Credit: Max Planck Institute for Biology of Ageing[/caption] RNA is an important transmitter of information in our cells…..

Carroucell has raised €1.5 million

Carroucell has raised €1.5 million Carroucell, a French microcarrier supplier for cell culture in bioreactor, has raised a total of €1.5 million. The funding includes the closing of a Series A financing, led by the Novalis Biotech Acceleration fund and with participation of Crédit Agricole des Savoie (CADS), as well…..